Ontology highlight
ABSTRACT: Background
Cognitive impairment is common in patients with end-stage renal disease receiving hemodialysis 3 times per week.Study design
Randomized clinical trial.Setting & participants
218 individuals participating in the Frequent Hemodialysis Network (FHN) Daily Trial and 81 participating in the FHN Nocturnal Trial.Intervention
The Daily Trial tested in-center hemodialysis 6 times per week versus 3 times per week. The Nocturnal Trial tested home nocturnal hemodialysis 6 times per week versus home or in-center hemodialysis 3 times per week.Outcomes
Cognitive function was measured at baseline, month 4, and month 12. The primary outcome was performance on the Trail-Making Test, Form B, a measure of executive function, and a secondary outcome was perfor
SUBMITTER: Kurella Tamura M
PROVIDER: S-EPMC3546160 | biostudies-literature | 2013 Feb
REPOSITORIES: biostudies-literature